The trademark application CSL SEQIRUS was filed by Seqirus UK Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on September 1, 2022, and it was registered by office on December 9, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 1 with following description of goods:
Chemical and biological reagents in this class
Cell cultures and media in this class
Laboratory and scientific test kits in this class
Chemical preparations for scientific and/or industrial purposes
Diagnostic and testing agents
Chemical and biological reagents for non-medical purposes
Chemical and biological reagents for industrial use for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes
Chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use
Chemical preparations for industrial use for anti-body screening, blood grouping, and the typing and detection of specific blood cells
None of the aforesaid goods being for the gut-brain-skin axis application, and / or alimentary tract wellbeing and/or prevention and treatment of digestive system diseases, and / or prevention and treatment of urogenital tract diseases, and / or skin nutrition, protection and treatment.
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations and substances in this class
Vaccines
Blood products
Products derived from blood and products derived from recombinant DNA technology
Serums
Antibodies
Medical and veterinary test kits
Influenza vaccines
Adjuvants and antigens
Pharmaceutical preparations and substances for the treatment and/or prevention of blood or bleeding disorders
Products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use
Serums, namely, anti-venoms
Medicated serums for the treatment of blood or bleeding disorders
Test kits, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response
Pharmaceutical preparations and substances, namely, RhD reagents for the detection of specific antigens or in blood typing
Pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies or IgG subtypes
Pharmaceutical preparations, namely, monoclonal and polyclonal antibodies
Pharmaceutical preparations, namely, reagents for medical/clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes
None of the aforesaid goods being for the gut-brain-skin axis application, and / or alimentary tract wellbeing and/or prevention and treatment of digestive system diseases, and / or prevention and treatment of urogenital tract diseases, and / or skin nutrition, protection and treatment.
The mark was filed in class 41 with following description of goods:
Education services including medical education services
Health education
Consultancy services relating to education
Provision of education services via an online forum
Provision of training and education courses
Publication of educational materials
Dissemination of educational material
Weblog (blog) services
Electronic publication of information on a wide range of topics, including online and over a global computer network.
The mark was filed in class 42 with following description of goods:
Scientific and technological services
Research and development services, including scientific, medical, pharmaceutical and blood products research and development services
Industrial analysis
Clinical trials
Conducting clinical trials
Provision of testing facilities
Rental of research facilities
Laboratory analysis and research
Management of scientific research projects
Preparation of technical studies, technical reports, scientific reports
Management of scientific research projects, preparation of scientific and medical research projects, preparation of statistics or reports relating to scientific and medical research
Provision of research services and facilities, provision of research results, information and outcomes
Provision of information relating to the aforementioned services
Advisory and consultancy services relating to the aforementioned services
Dissemination of information relating to the aforementioned services over a global computer network
Medical laboratory services, namely, scientific testing and screening services, namely, testing of human blood plasma for safety and quality
Medical laboratory services regarding human blood plasma.
The mark was filed in class 44 with following description of goods:
Medical services
Medical information services
Health care services
Health care information services
Patient support services
Providing medical information concerning blood products
Providing medical information concerning vaccines, anti-venoms and immunohaematology products, namely, diagnostic reagents
Patient support services, namely, providing patient medical information where patients can enquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community via an Internet-based database.